Clinical trial
Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
NCT03103074 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
- Lead sponsor
- University Hospital of North Norway
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- September 23, 2018
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.